Dermira
Acquired
- Headquarters
- Menlo Park, California
- Employees
- 201–500
- Founded
- 2010
- Business Model
- B2B
- Website
- dermira.com
- Total Funding
- $202.0M
- Last Round
- $125.0M Venture RoundOct 2014
About
Dermira was a specialty biopharmaceutical company dedicated to developing differentiated therapies for chronic skin conditions. Based in Menlo Park, California, Dermira developed lebrikizumab (an IL-13 antibody for atopic dermatitis) and Qbrexza (for hyperhidrosis). The company was acquired by Eli Lilly for approximately $1.1 billion in 2020.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account